Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 101–200 of 1,000
Mannose‐binding lectin engagement with late apoptotic and necrotic cells
Nauta, A. J., Raaschou‐Jensen, N., Roos, A., Daha, M. R., Madsen, H. O., Borrias‐Essers, M. C., Ryder, L. P., Koch, C., & Garred, P. (2003) · European Journal of Immunology · doi:10.1002/eji.200323888 · Cited by 322
The phosphatidylserine receptor: a crucial molecular switch?
Henson, P. M., Bratton, D. L., & Fadok, V. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085094 · Cited by 321
Complement and systemic lupus erythematosus.
Walport, M. J. (2002) · Arthritis Research · doi:10.1186/ar586 · Cited by 361
“An excess of apoptotic cells was observed in kidneys from C1q-deficient mice [152].”
BackgroundSelf-citationComplement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes
Naito, A. T., Sumida, T., Nomura, S., Liu, M.-L., Higo, T., Nakagawa, A., Okada, K., Sakai, T., Hashimoto, A., Hara, Y., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.047 · Cited by 320
“C1qa-deficient mice (Botto et al., 1998) and C3-deficient mice (Wessels et al.”
Self-citationComplement facilitates early prion pathogenesis
Klein, M. A., Kaeser, P. S., Schwarz, P., Weyd, H., Xenarios, I., Zinkernagel, R. M., Carroll, M. C., Verbeek, J. S., Botto, M., Walport, M. J., et al. (2001) · Nature Medicine · doi:10.1038/86567 · Cited by 318
Self-citationCutting Edge: Bystander Apoptosis Triggers Dendritic Cell Maturation and Antigen-Presenting Function
Rovere, P., Vallinoto, C., Bondanza, A., Crosti, M. C., Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C., & Manfredi, A. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4467 · Cited by 309
Bulla, R., Tripodo, C., Rami, D., Ling, G. S., Agostinis, C., Guarnotta, C., Zorzet, S., Durigutto, P., Botto, M., & Tedesco, F. (2016) · Nature Communications · doi:10.1038/ncomms10346 · Cited by 294
Self-citationC1q, Autoimmunity and Apoptosis
BOTTO, M. (2002) · Immunobiology · doi:10.1078/0171-2985-00141 · Cited by 289
Self-citationBioeffects of moderate-intensity static magnetic fields on cell cultures
Dini, L., & Abbro, L. (2005) · Micron · doi:10.1016/j.micron.2004.12.009 · Cited by 288
Mitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032417.73640.72 · Cited by 287
“Ultrastructural studies have demonstrated apoptotic uptake by M in glomerulonephritis (31), whereas the persistence of apoptotic bodies in the glomeruli of C1q-deficient mice is indicative of impaired clearance (32).”
BackgroundThe macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?
Gregory, C. D., & Devitt, A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01959.x · Cited by 285
Kim, S. J., Gershov, D., Ma, X., Brot, N., & Elkon, K. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020542 · Cited by 282
“The observations that mice with disruption of genes encoding Dnase 1 (3), C1q (4), or acute phase proteins (5) also develop lupus and that C1q and CRP opsonize dying cells for phagocytosis by macrophages in vitro (6, 7), support the argument that defective clearance of dying cells predisposes to lupuslike diseases.”
BackgroundFifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth
Roumenina, L. T., Daugan, M. V., Noé, R., Petitprez, F., Vano, Y. A., Sanchez-Salas, R., Becht, E., Meilleroux, J., Clec'h, B. L., Giraldo, N. A., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0891 · Cited by 269
“Marina Botto (Imperial College London) were bred in our animal facility as previously described (22,23).”
MethodSelf-citationComplement and the Regulation of T Cell Responses
West, E. E., Kolev, M., & Kemper, C. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053245 · Cited by 269
“efficient removal of ICs and dying cells and are therefore associated with IC disorders (36, 37) and the autoimmune disease systemic lupus erythematosus (SLE), respectively (8, 38, 39).”
BackgroundAsano, K., Miwa, M., Miwa, K., Hanayama, R., Nagase, H., Nagata, S., & Tanaka, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040342 · Cited by 267
“Both Mer- and C1q-deficient mice spontaneously showed autoantibody production, and developed glomerulonephritis (27, 33).”
BackgroundNavratil, J. S., Watkins, S. C., Wisnieski, J. J., & Ahearn, J. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3231 · Cited by 262
“(68) demonstrated that mice deficient in C1q spontaneously develop antinuclear Abs and glomerulonephritis, coupled with the accumulation of apoptotic bodies in the glomeruli.”
BackgroundVerbovetski, I., Bychkov, H., Trahtemberg, U., Shapira, I., Hareuveni, M., Ben-Tal, O., Kutikov, I., Gill, O., & Mevorach, D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020263 · Cited by 262
“The possible importance of complement-mediated opsonization of apoptotic cells was further shown by the development of systemic lupus erythematosus in 90% of homozygous patients with C1q deficiency, in 75% of homozygous patients with C4 deficiency, and by the development of glomerulonephritis associated with increased…”
BackgroundComplosome — the intracellular complement system
West, E. E., & Kemper, C. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00704-1 · Cited by 253
Development and selection of marginal zone B cells
Lopes‐Carvalho, T., & Kearney, J. F. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0112.x · Cited by 253
“Lupus-prone mouse strains show impaired clearance of apoptotic cells (142), and conversely, strains where genes needed for housekeeping debris-clearance functions are disrupted show lupus-like symptoms (19, 20).”
BackgroundRho GTPase signalling pathways in the morphological changes associated with apoptosis
Coleman, M. L., & Olson, M. F. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400987 · Cited by 251
Szondy, Z., Sarang, Z., Molnár, P., Németh, T., Piacentini, M., Mastroberardino, P. G., Falasca, L., Aeschlimann, D., Kovács, J., Kiss, I., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832466100 · Cited by 251
Apoptosis in Human Disease: A New Skin for the Old Ceremony?
Fadeel, B., Orrenius, S., & Zhivotovsky, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1888 · Cited by 249
Benoit, M. E., Clarke, E. V., Morgado, P., Fraser, D. A., & Tenner, A. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103760 · Cited by 246
NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus
Campbell, A. M., Kashgarian, M., & Shlomchik, M. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004801 · Cited by 246
Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies
Ehrenstein, M. R., Cook, H. T., & Neuberger, M. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1253 · Cited by 246
Self-citationTrouw, L. A., Groeneveld, T. W. L., Seelen, M. A., Duijs, J. M. G. J., Bajema, I. M., Prins, F. A., Kishore, U., Salant, D. J., Verbeek, J. S., Kooten, C. V., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421075 · Cited by 245
“Since C1q–/– mice are reported to be autoimmune-prone if on a mixed genetic background (27), we used non–autoimmuneprone C1q–/– mice on a full C57BL/6 background (28) to avoid the generation of polyreactive autoantibodies.”
MethodImmunological Consequences of Apoptotic Cell Phagocytosis
Erwig, L.-P., & Henson, P. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070135 · Cited by 242
Walsh, M. C., Bourcier, T., Takahashi, K., Shi, L., Busche, M. N., Rother, R. P., Solomon, S. D., Ezekowitz, R. A. B., & Stahl, G. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.541 · Cited by 240
“C57BL/6 (wild type (WT)), C1qa / (C1q knockout (KO)) (18), C2 and factor B / (C2/fB KO) (19) factor D / (fD KO) (20), and C1q/fD / (lectin or C1q/fD KO) mice were obtained from Charles River Laboratories.”
THE ENGULFMENT PROCESS OF PROGRAMMED CELL DEATH IN CAENORHABDITIS ELEGANS
Reddien, P. W., & Horvitz, H. R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.022003.114619 · Cited by 240
“Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.”
BackgroundInfluentialHow apoptotic cells aid in the removal of their own cold dead bodies
Wickman, G., Julian, L., & Olson, M. F. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.25 · Cited by 238
“The importance of this mechanism for triggering clearance is underscored by the autoimmune disorders observed in C1q-deficient mice.(43)”
BackgroundThe Role of Complement in B Cell Activation and Tolerance
Carroll, M. C. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60908-6 · Cited by 238
C1q: A fresh look upon an old molecule
Thielens, N. M., Tedesco, F., Bohlson, S. S., Gaboriaud, C., & Tenner, A. J. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.025 · Cited by 237
“In addition, either complete genetic C1q deficiency in mice, or a lower production of C1q by murine peritoneal macrophages, has been linked to the presence of autoantibodies and murine lupus nephritis (Botto et al., 1998; Miura-Shimura et al., 2002).”
BackgroundOpsonization with C1q and Mannose-Binding Lectin Targets Apoptotic Cells to Dendritic Cells
Nauta, A. J., Castellano, G., Xu, W., Woltman, A. M., Borrias, M. C., Daha, M. R., van Kooten, C., & Roos, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3044 · Cited by 236
“Moreover, C1qdeficient mice spontaneously develop autoantibodies and glomerulonephritis associated with the presence of multiple apoptotic cells in the kidney (4), consistent with demonstrable defects in the clearance of apoptotic cells by their macrophages (6).”
BackgroundFoster, C. B., Lehrnbecher, T., Mol, F., Steinberg, S. M., Venzon, D. J., Walsh, T. J., Noack, D., Rae, J., Winkelstein, J. A., Curnutte, J. T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci5084 · Cited by 236
“Recently, it has been suggested that the association of C1q deficiency and lupus disorders may be related to defective clearance of cells undergoing apoptosis (80).”
BackgroundApoptotic cells induce Mer tyrosine kinase–dependent blockade of NF-κB activation in dendritic cells
Sen, P., Wallet, M. A., Yi, Z., Huang, Y., Henderson, M., Mathews, C. E., Earp, H. S., Matsushima, G., Baldwin, A. S., & Tisch, R. M. (2007) · Blood · doi:10.1182/blood-2006-04-017368 · Cited by 235
Dejean, A. S., Beisner, D. R., Ch'en, I. L., Kerdiles, Y. M., Babour, A., Arden, K. C., Castrillon, D. H., DePinho, R. A., & Hedrick, S. M. (2009) · Nature Immunology · doi:10.1038/ni.1729 · Cited by 235
“Several studies have noted modifier genes in 129 strains that confer enhanced autoimmune disease to 129 × C57BL/6 mic”
BackgroundRecognition and clearance of apoptotic cells: a role for complement and pentraxins
Nauta, A. J., Daha, M. R., Kooten, C. V., & Roos, A. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00030-9 · Cited by 231
DNA DEGRADATION IN DEVELOPMENT AND PROGRAMMED CELL DEATH
Nagata, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115811 · Cited by 230
Is resolution the end of inflammation?
Feehan, K. T., & Gilroy, D. W. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.006 · Cited by 229
Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα
Eriksson, C., Engstrand, S., Sundqvist, K.-G., & Rantapää-Dahlqvist, S. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.024182 · Cited by 228
Dai, X., Fan, Y., & Zhao, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02168-0 · Cited by 226
Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia
Mocco, J., Mack, W. J., Ducruet, A. F., Sosunov, S. A., Sughrue, M. E., Hassid, B. G., Nair, M. N., Laufer, I., Komotar, R. J., Claire, M., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000232544.90675.42 · Cited by 226
TLR7 and TLR9 in SLE: when sensing self goes wrong
Celhar, T., Magalhães, R., & Fairhurst, A.-M. (2012) · Immunologic Research · doi:10.1007/s12026-012-8270-1 · Cited by 225
“Concordantly, C1q-deficient mice develop a lupus-like disease characterized by increased apoptotic bodies in the glomeruli in vivo and by decreased apoptotic cell uptake by C1q macrophages in vitro and in vivo [168, 171].”
BackgroundC1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression
Mitchell, D. A., Pickering, M. C., Warren, J., Fossati-Jimack, L., Cortes-Hernandez, J., Cook, H. T., Botto, M., & Walport, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2538 · Cited by 225
“Elevated numbers of apoptotic bodies were present in the glomeruli of nondiseased C1qa / animals compared with wild-type controls (2).”
BackgroundSelf-citationControl of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53
Yoon, K. W., Byun, S., Kwon, E., Hwang, S.-Y., Chu, K., Hiraki, M., Jo, S.-H., Weins, A., Hakroush, S., Cebulla, A., et al. (2015) · Science · doi:10.1126/science.1261669 · Cited by 224
Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J., & Pepys, M. B. (2001) · Nature Medicine · doi:10.1038/86562 · Cited by 224
Self-citationPhagocytosis of apoptotic cells and the resolution of inflammation
Maderna, P., & Godson, C. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.09.004 · Cited by 222
Chen, Y., Park, Y.-B., Patel, E., & Silverman, G. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804191 · Cited by 221
The interferon-α signature of systemic lupus erythematosus
Obermoser, G., & Pascual, V. (2010) · Lupus · doi:10.1177/0961203310371161 · Cited by 220
Elward, K. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00109-3 · Cited by 219
Disassembly of the Dying: Mechanisms and Functions
Atkin-Smith, G. K., & Poon, I. K. H. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.08.011 · Cited by 218
Van BEEK, J., ELWARD, K., & GASQUE, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03138.x · Cited by 218
Nucleosomes Are Exposed at the Cell Surface in Apoptosis
Radic, M., Marion, T., & Monestier, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6692 · Cited by 218
“Deficiencies in serum proteins that assist in the recognition and clearance of apoptotic cells increase the risk of systemic autoimmune disease (3, 4).”
BackgroundGregory, C. D., & Pound, J. D. (2011) · The Journal of Pathology · doi:10.1002/path.2792 · Cited by 215
Cd5 Maintains Tolerance in Anergic B Cells
Hippen, K. L., Tze, L. E., & Behrens, T. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.883 · Cited by 215
Morimoto, K., Janssen, W. J., Fessler, M. B., McPhillips, K. A., Borges, V. M., Bowler, R. P., Xiao, Y.-Q., Kench, J. A., Henson, P. M., & Vandivier, R. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7657 · Cited by 215
“Discussion Apoptotic cell clearance defects are increasingly recognized in diseases of chronic inflammation (31, 32) and autoimmunity (33, 34, 67, 68), suggesting that effective efferocytosis may be necessary for the maintenance of homeostasis.”
BackgroundWasp in immune-system organization and function
Thrasher, A. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri884 · Cited by 215
“Similar defects are apparent during the phagocytosis of apoptotic cells both in vitro and in vivo , which, given the interest in the clearance of cellular debris for the suppression of tissue inflammation and prevention of autoimmunity, might have important implications for the pathophysiology of clinical disease in WA”
The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity
Ramirez-Ortiz, Z. G., Pendergraft, W. F., Prasad, A., Byrne, M. H., Iram, T., Blanchette, C. J., Luster, A. D., Hacohen, N., Khoury, J. E., & Means, T. K. (2013) · Nature Immunology · doi:10.1038/ni.2670 · Cited by 214
Impaired clearance of dying cells in systemic lupus erythematosus
Gaipl, U. S., Voll, R. E., Sheriff, A., Franz, S., Kalden, J. R., & Herrmann, M. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.10.007 · Cited by 213
Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis
Mistry, P., & Kaplan, M. J. (2017) · Clinical Immunology · doi:10.1016/j.clim.2016.08.010 · Cited by 213
“C1q-deficient mice develop immune complex nephritis and accumulation of renal apoptotic bodies (92).”
BackgroundNatural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
Stäger, S., Alexander, J., Kirby, A. C., Botto, M., Rooijen, N. V., Smith, D. F., Brombacher, F., & Kaye, P. M. (2003) · Nature Medicine · doi:10.1038/nm933 · Cited by 213
Self-citationGhai, R., Waters, P., Roumenina, L. T., Gadjeva, M., Kojouharova, M. S., Reid, K. B. M., Sim, R. B., & Kishore, U. (2007) · Immunobiology · doi:10.1016/j.imbio.2006.11.001 · Cited by 212
WARNATZ, K. (2002) · Immunobiology · doi:10.1078/0171-2985-00198 · Cited by 211
Complementing the Cancer-Immunity Cycle
Pio, R., Ajona, D., Ortiz-Espinosa, S., Mantovani, A., & Lambris, J. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00774 · Cited by 211
Böse, J., Gruber, A. D., Helming, L., Schiebe, S., Wegener, I., Hafner, M., Beales, M., Köntgen, F., & Lengeling, A. (2004) · Journal of Biology · doi:10.1186/jbiol10 · Cited by 210
“This has been reported for knockout mice lacking the complement protein C1q [15], for mice with a mutation in the tyrosine kinase receptor gene Mer [16] and, more recently, in mice lacking transglutaminase 2 or milk fat globule epidermal growth factor 8 (MFG-E8) [17,18].”
BackgroundThe evolution of human anti-double-stranded DNA autoantibodies
Wellmann, U., Letz, M., Herrmann, M., Angermüller, S., Kalden, J. R., & Winkler, T. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500132102 · Cited by 210
Polyglycolic Acid-Induced Inflammation: Role of Hydrolysis and Resulting Complement Activation
Ceonzo, K., Gaynor, A., Shaffer, L., Kojima, K., Vacanti, C. A., & Stahl, G. L. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.301 · Cited by 209
“Six-week-old mice C57/BL6 wild type (WT), C1qa −/− (KO)(24), factor D KO(21), C2/factor B KO(25), C1q/factor D KO, C6 deficient mice(12) were Ceonzo et al.”
Watanabe, H., Garnier, G., Circolo, A., Wetsel, R. A., Ruiz, P., Holers, V. M., Boackle, S. A., Colten, H. R., & Gilkeson, G. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.786 · Cited by 207
Stuart, L. M., Takahashi, K., Shi, L., Savill, J., & Ezekowitz, R. A. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3220 · Cited by 205
“In further support of this “waste disposal” model, C1q-deficient mice, upon certain backgrounds, develop a lupus-like syndrome and nephritis characterized by multiple uncleared apoptotic cells (13).”
BackgroundPhagocytosis of Necrotic Debris at Sites of Injury and Inflammation
Westman, J., Grinstein, S., & Marques, P. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03030 · Cited by 203
Innate Immune Cells' Contribution to Systemic Lupus Erythematosus
Herrada, A. A., Escobedo, N., Iruretagoyena, M., Valenzuela, R. A., Burgos, P. I., Cuitino, L., & Llanos, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00772 · Cited by 202
“One called the “waste disposal hypothesis,” suggests that the complement cascade eliminates apoptotic cells and debris, therefore preventing the accumulation of self-antigens that could activate adaptive immune cells (83).”
BackgroundSLE—a disease of clearance deficiency?
Munoz, L. E., Gaipl, U. S., Franz, S., Sheriff, A., Voll, R. E., Kalden, J. R., & Herrmann, M. (2005) · Rheumatology · doi:10.1093/rheumatology/keh693 · Cited by 202
“C1q knockout mice also show apoptotic material in renal tissues together with glomerulonephritis [66].”
BackgroundVerschoor, A., Neuenhahn, M., Navarini, A. A., Graef, P., Plaumann, A., Seidlmeier, A., Nieswandt, B., Massberg, S., Zinkernagel, R. M., Hengartner, H., et al. (2011) · Nature Immunology · doi:10.1038/ni.2140 · Cited by 201
Wood, W., Turmaine, M., Weber, R., Camp, V., Maki, R. A., McKercher, S. R., & Martin, P. (2000) · Development · doi:10.1242/dev.127.24.5245 · Cited by 201
Complement Component 1Q (C1Q) Upregulation in Retina of Murine, Primate, and Human Glaucomatous Eyes
Stasi, K., Nagel, D., Yang, X., Wang, R.-F., Ren, L., Podos, S. M., Mittag, T., & Danias, J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0830 · Cited by 200
C1q restrains autoimmunity and viral infection by regulating CD8 + T cell metabolism
Ling, G. S., Crawford, G., Buang, N., Bartok, I., Tian, K., Thielens, N. M., Bally, I., Harker, J. A., Ashton-Rickardt, P. G., Rutschmann, S., et al. (2018) · Science · doi:10.1126/science.aao4555 · Cited by 199
Self-citationBohlson, S. S., Fraser, D. A., & Tenner, A. J. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.021 · Cited by 198
Fraser, D. A., Pisalyaput, K., & Tenner, A. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06494.x · Cited by 196
“A multifunctional protein, C1q recognizes apoptotic cells and plays a vital role in their clearance as evidenced by the association of C1q deficiency with an accumulation of apoptotic cells and lupus-like disease in mice (Botto et al. 1998).”
BackgroundStructural and functional anatomy of the globular domain of complement protein C1q
Kishore, U., Ghai, R., Greenhough, T. J., Shrive, A. K., Bonifati, D. M., Gadjeva, M. G., Waters, P., Kojouharova, M. S., Chakraborty, T., & Agrawal, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.015 · Cited by 195
Beyond lysis: how complement influences cell fate
COLE, D. S., & MORGAN, B. P. (2003) · Clinical Science · doi:10.1042/cs20020362 · Cited by 195
Toll-like Receptor 2 Senses β-Cell Death and Contributes to the Initiation of Autoimmune Diabetes
Kim, H. S., Han, M. S., Chung, K. W., Kim, S., Kim, E., Kim, M. J., Jang, E., Lee, H. A., Youn, J., Akira, S., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.010 · Cited by 195
Hart, M. L., Ceonzo, K. A., Shaffer, L. A., Takahashi, K., Rother, R. P., Reenstra, W. R., Buras, J. A., & Stahl, G. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6373 · Cited by 195
“C57BL/6 (WT), C1qa KO (C1qKO) (27), C2/factor B double-KO (C2/fB KO) (28), *Center for Experimental Therapeutics and Reperfusion Injury, Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, and Laboratory of Developmental Immunology, Massachusetts General Hospital for Children, Harvard Medica…”
BackgroundRole of complement and complement regulators in the removal of apoptotic cells
Trouw, L. A., Blom, A. M., & Gasque, P. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.008 · Cited by 192
Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency
Zhang, J., Velmeshev, D., Hashimoto, K., Huang, Y.-H., Hofmann, J. W., Shi, X., Chen, J., Leidal, A. M., Dishart, J. G., Cahill, M. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2709-7 · Cited by 191
The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development
Balomenos, D., Martín-Caballero, J., García, M. I., Prieto, I., Flores, J. M., Serrano, M., & Martínez-A, C. (2000) · Nature Medicine · doi:10.1038/72272 · Cited by 191
Fishelson, Z. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00055-4 · Cited by 190
Epistatic Modifiers of Autoimmunity in a Murine Model of Lupus Nephritis
Morel, L., Tian, X.-H., Croker, B. P., & Wakeland, E. K. (1999) · Immunity · doi:10.1016/s1074-7613(00)80088-6 · Cited by 190
Role of Complement Component C1q in the Onset of Preeclampsia in Mice
Singh, J., Ahmed, A., & Girardi, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175919 · Cited by 187
CD14-dependent clearance of apoptotic cells: relevance to the immune system
Gregory, C. D. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00047-3 · Cited by 187
Bygrave, A. E., Rose, K. L., Cortes-Hernandez, J., Warren, J., Rigby, R. J., Cook, H. T., Walport, M. J., Vyse, T. J., & Botto, M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020243 · Cited by 186
Self-citationModulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.
Mika, J. (2008) · PubMed · Cited by 211
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Braun, D. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00109-9 · Cited by 182
Beers, S. A., Chan, C. H. T., James, S., French, R. R., Attfield, K. E., Brennan, C. M., Ahuja, A., Shlomchik, M. J., Cragg, M. S., & Glennie, M. J. (2008) · Blood · doi:10.1182/blood-2008-04-149161 · Cited by 180
Zhang, W., Xu, W., & Xiong, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904016 · Cited by 177
The complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration
Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05668.x · Cited by 177
“1996), inflammatory pathology and some behavioral deficiencies were crossed to mice containing a targeted deletion of the gene encoding C1q (Botto et al. 1998).”
BackgroundC1q and HMGB1 reciprocally regulate human macrophage polarization
Son, M., Porat, A., He, M., Suurmond, J., Santiago-Schwarz, F., Andersson, U., Coleman, T. R., Volpe, B. T., Tracey, K. J., Al-Abed, Y., et al. (2016) · Blood · doi:10.1182/blood-2016-05-719757 · Cited by 177
The genetics of human systemic lupus erythematosus
Tsao, B. P. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.006 · Cited by 177
Kollias, G., & Kontoyiannis, D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00019-9 · Cited by 177
“Their absence in mice leads to the development of anti-nuclear autoimmunity and lupus-like disease [66,67].”
BackgroundFollicular dendritic cells: origin, phenotype, and function in health and disease
Aguzzi, A., Kranich, J., & Krautler, N. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.11.001 · Cited by 176
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.